Amarin Corp Plc (AMRN)

[centurycom]

Perhaps the FDA is approaching many problems the wrong way. For instance, high Trigs is a symptom of a problem. Just because a drug fixes a symptom does not mean that its unique mechanism of action will not solve a problem related to that symptom. So when they state that because two other drugs that address a symptom have no effect on relieving CVT disease doesn't necessarily mean that a third drug which has a long history, by the way, of having a beneficual relationship should be treated in the same manner as those that do not.